Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3234
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05038098 | Magnetic Sentinel Lymph Node Mapping in Gastric Cancer | ||
| NCT02882321 | Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT05293509 | Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders | ||
| NCT06121232 | Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study | ||
| NCT00529464 | Spectroscopy Versus Standard Care in Cervical Cancer Patients | ||
| NCT01187199 | Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer | ||
| NCT02348398 | Phase II Study of Pazopanib and Topotecan in Cervical Cancer | ||
| NCT03690921 | Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial | ||
| NCT05075993 | Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors | ||
| NCT01199198 | Tolvaptan in Hyponatremic Cancer Patients | ||
| NCT03555721 | CytID Analysis of Oral Lesions | ||
| NCT03065387 | Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation | ||
| NCT01746836 | Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib | ||
| NCT00609609 | Photopheresis for the Treatment of Acute Graft Versus Host Disease | ||
| NCT07224152 | NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer | ||
| NCT03592459 | Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer | ||
| NCT07414979 | Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma | ||
| NCT03128879 | Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL | ||
| NCT03052075 | Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism | ||
| NCT00501228 | Tissue Repair in Stem Cell Transplant Recipients | ||
| NCT04259905 | Pink Warrior 2: Teleconference-based Gaming Support | ||
| NCT04751422 | Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine | ||
| NCT00487357 | MATCh Parents' Supplemental Survey | ||
| NCT00512551 | DNA Array Analysis of Patients With Cervical Cancer | ||
| NCT00867230 | FTS Study in Patients With Advanced Hematologic Malignancies | ||
| NCT00423436 | Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients | ||
| NCT01550900 | Prospective Trial of Metformin - Chemoprevention Role | ||
| NCT01492036 | Long-Term Follow-Up of Recipient of Gene Transfer Research | ||
| NCT00942734 | Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma | ||
| NCT01037751 | M. D. Anderson Symptom Inventory - Ovarian Cancer | ||
| NCT00800839 | Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide | ||
| NCT02736357 | The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study | ||
| NCT01630564 | Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies | ||
| NCT04759911 | Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer | ||
| NCT00688038 | Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy | ||
| NCT00147225 | AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | ||
| NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | ||
| NCT00553059 | Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer | ||
| NCT01444742 | Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) | ||
| NCT01436240 | Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | ||
| NCT03929159 | Correlating MicroRNA Changes With Sepsis Outcomes | ||
| NCT03114462 | Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer | ||
| NCT03471260 | Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies | ||
| NCT00953420 | Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes | ||
| NCT04311723 | Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial | ||
| NCT05064280 | Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases | ||
| NCT04178174 | Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer | ||
| NCT05961696 | A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia | ||
| NCT04228042 | Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer | ||
| NCT02964182 | Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers |
